Adaptive Biotechnologies (ADPT) Other Working Capital Changes (2018 - 2026)

Adaptive Biotechnologies has disclosed Other Working Capital Changes across 9 years of filings, most recently posting $1.7 million for Q2 2026.

• In Q2 2026, Other Working Capital Changes rose 242.45% year-over-year to $1.7 million; the TTM figure through Jun 2026 stood at $4.3 million (up 851.01% YoY), while the FY2025 annual figure was $1.7 million, up 2187.95% from the prior year.
• Other Working Capital Changes came in at $1.7 million for Q2 2026 at Adaptive Biotechnologies, up from $824000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $4.0 million in Q1 2026 to a low of -$32.8 million in Q3 2025.
• Average Other Working Capital Changes over 5 years is -$7.0 million, with a median of -$5.8 million recorded in 2023.
• Year-over-year, Other Working Capital Changes surged 9969.77% in 2023 and sank 531.82% in 2024.
• Over 5 years, Other Working Capital Changes stood at -$2.9 million in 2022, then jumped by 31.05% to -$2.0 million in 2023, then soared by 52.8% to -$960000.0 in 2024, then rose by 16.77% to -$799000.0 in 2025, then surged by 313.02% to $1.7 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $1.7 million in Q2 2026, $824000.0 in Q1 2026, and -$799000.0 in Q4 2025.